Vaccine confidence and potential implications for new tuberculosis vaccines
This analysis underscores the importance of monitoring vaccine confidence levels to address emerging challenges to maintaining or bolstering the public's trust in vaccination. Our findings could help determine which countries to prioritise for social mobilisation and demand generation efforts to boost vaccine confidence, and thus improve readiness for new TB vaccines.
Authors
- Rupali J. Limaye (ORCID: https://orcid.org/0000-0002-3883-9720)
- Puck T. Pelzer (ORCID: https://orcid.org/0000-0003-1648-0304)
- Richard Guy White (ORCID: https://orcid.org/0000-0003-4410-6635)
- Rebecca A. Clark (ORCID: https://orcid.org/0000-0003-1166-2272)
- Shaun Palmer
- Zsofia M. Hesketh
Institutions
- International AIDS Vaccine Initiative (US)
- Gavi (CH)
- Johns Hopkins University (US)
- London School of Hygiene & Tropical Medicine (GB)
- Community Partners (US)
Publication Details
- Journal
- BMC Global and Public Health
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1186/s44263-025-00216-z
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- London School of Hygiene and Tropical Medicine
- Wellcome Trust
- Open Philanthropy Project
- Good Ventures Foundation
- National Institutes of Health
- Medical Research Council
- Economic and Social Research Council
- European and Developing Countries Clinical Trials Partnership